Prognostic Significance of Targetable Angiogenic and Growth Factors in Patients Undergoing Resection for Gastric and Gastroesophageal Junction Cancers
作者： Do Joong Park , Changhwan Yoon , Nicholas Thomas , Geoffrey Y. Ku , Yelena Y. Janjigian
DOI: 10.1245/S10434-013-3429-0
关键词: Gastroesophageal Junction 、 Surgical oncology 、 Oncology 、 Hepatocyte growth factor 、 Tumor progression 、 In patient 、 Gastroenterology 、 Internal medicine 、 Metastasis 、 Medicine 、 Resection 、 Surgery
摘要: Background Circulating factors in patients with gastric/gastroesophageal junction (GEJ) cancers may promote tumor progression and metastasis be targeted for therapy.
springer.com
sci-hub.se 参考文章(20)
Marco Alessandro Pierotti, Alessandro Pellegrinelli, Filippo Pietrantonio, Maria Di Bartolomeo, Federica Perrone, Manuela Gariboldi, Ilaria Bossi, Filippo De Braud, Valentina Da Prat, Pamela Biondani, Giuseppe Fanetti, A review on biomarkers for prediction of treatment outcome in gastric cancer Anticancer Research. ,vol. 33, pp. 1257- 1266 ,(2013)
Yelena Y. Janjigian, David P. Kelsen, Genomic dysregulation in gastric tumors. Journal of Surgical Oncology. ,vol. 107, pp. 237- 242 ,(2013) , 10.1002/JSO.23263
Ferdinando De Vita, Francesco Giuliani, Nicola Silvestris, Sabrina Rossetti, Antonio Pizzolorusso, Giuseppe Santabarbara, Gennaro Galizia, Giuseppe Colucci, Fortunato Ciardiello, Michele Orditura, Current status of targeted therapies in advanced gastric cancer Expert Opinion on Therapeutic Targets. ,vol. 16, pp. S29- S34 ,(2012) , 10.1517/14728222.2011.652616
Catherine Oakman, Libero Santarpia, Angelo Di Leo, Breast cancer assessment tools and optimizing adjuvant therapy Nature Reviews Clinical Oncology. ,vol. 7, pp. 725- 732 ,(2010) , 10.1038/NRCLINONC.2010.170
Masuko Katoh, Masaru Katoh, FGF signaling network in the gastrointestinal tract (Review) International Journal of Oncology. ,vol. 29, pp. 163- 168 ,(2006) , 10.3892/IJO.29.1.163
Fabiola Cecchi, Daniel C Rabe, Donald P Bottaro, Targeting the HGF/Met signaling pathway in cancer therapy. Expert Opinion on Therapeutic Targets. ,vol. 16, pp. 553- 572 ,(2012) , 10.1517/14728222.2012.680957
Jiping Wang, Ping Dang, Chandrajit P. Raut, Prakash K. Pandalai, Ugwuji N. Maduekwe, David W. Rattner, Gregory Y. Lauwers, Sam S. Yoon, Comparison of a Lymph Node Ratio–Based Staging System With the 7th AJCC System for Gastric Cancer Annals of Surgery. ,vol. 255, pp. 478- 485 ,(2012) , 10.1097/SLA.0B013E31824857E2
F. van Valen, H. Hanenberg, H. Jürgens, Expression of functional very late Antigen-α1, -α2, -α3 and -α6 integrins on Ewing's sarcoma and primitive peripheral neuroectodermal tumour cells and modulation by interferon-γ and tumour necrosis factor-α European Journal of Cancer. ,vol. 30, pp. 2119- 2125 ,(1994) , 10.1016/0959-8049(94)00346-7
Niantao Deng, Liang Kee Goh, Hannah Wang, Kakoli Das, Jiong Tao, Iain Beehuat Tan, Shenli Zhang, Minghui Lee, Jeanie Wu, Kiat Hon Lim, Zhengdeng Lei, Glenn Goh, Qing-Yan Lim, Angie Lay-Keng Tan, Dianne Yu Sin Poh, Sudep Riahi, Sandra Bell, Michael M Shi, Ronald Linnartz, Feng Zhu, Khay Guan Yeoh, Han Chong Toh, Wei Peng Yong, Hyun Cheol Cheong, Sun Young Rha, Alex Boussioutas, Heike Grabsch, Steve Rozen, Patrick Tan, A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets Gut. ,vol. 61, pp. 673- 684 ,(2012) , 10.1136/GUTJNL-2011-301839
Yung-Jue Bang, Eric Van Cutsem, Andrea Feyereislova, Hyun C Chung, Lin Shen, Akira Sawaki, Florian Lordick, Atsushi Ohtsu, Yasushi Omuro, Taroh Satoh, Giuseppe Aprile, Evgeny Kulikov, Julie Hill, Michaela Lehle, Josef Rüschoff, Yoon-Koo Kang, None, Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial The Lancet. ,vol. 376, pp. 687- 697 ,(2010) , 10.1016/S0140-6736(10)61121-X